In patients with advanced ovarian cancer who undergo primary surgery, factors such as surgical complexity have a significant effect on short-term morbidity and overall survival, according to a report published in the December issue of the American Journal of Obstetrics and Gynecology.
In patients with advanced ovarian cancer who undergo primary surgery, factors such as surgical complexity have a significant effect on short-term morbidity and overall survival, according to a report published in the December issue of the American Journal of Obstetrics and Gynecology.
Giovanni D. Aletti, MD, of the Mayo Clinic in Rochester, MN., and colleagues studied 219 patients with stage IIIC-IV ovarian cancer.
The researchers found that poor performance status, age, and extent or complexity of surgery were all independently associated with major morbidity. They found that age and performance status-but not surgical complexity-predicted 3-month mortality. They also observed that surgical complexity independently predicted overall survival. Among the risk prediction categories developed by the researchers, the risk of expected complications ranged from 2.5% to 67.6%. In all risk groups, however, more complex surgery carried a survival benefit.
"Because of the survival benefit from lower residual disease, a less aggressive surgical effort results in poorer overall survival," the authors conclude. "However, the risk of complications are substantial for complex surgeries in the highest-risk patients: risk stratification should be used to help plan perioperative care and consider optimal treatment planning."
Aletti GD, Dowdy SC, Podratz KC, et al. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007;197:676.e1-676.e7.
A legacy of excellence: Reflecting on the final print edition of Contemporary OB/GYN
April 25th 2025Marking the end of an era and the beginning of a new chapter, the final print edition of Contemporary OB/GYN celebrates over 50 years of evidence-based guidance and unwavering support for clinicians.
Read More